Different effects of the hypolipidemic drugs pravastatin and lovastatin on the cholesterol biosynthesis of the human ocular lens in organ culture and on the cholesterol content of the rat lens in vivo

This publication has 20 references indexed in Scilit:

• Tissue-selective action of pravastatin due to hepatocellular uptake via a sodium-independent bile acid transporter
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1992
• Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture
  Biochemical Pharmacology, 1992
• Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and Simvastatin
  Journal of Pharmaceutical Sciences, 1991
• 8-(Dicyclopropylmethyl)-1,3-dipropylxanthine: a potent and selective adenosine A1 antagonist with renal protective and diuretic activities
  Journal of Medicinal Chemistry, 1991
• Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
• The clinical efficacy and safety of lovastatin and MK-733--an overview
  European Heart Journal, 1987
• CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
• 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side-chain ester derivatives of mevinolin
  Journal of Medicinal Chemistry, 1986
• A Receptor-Mediated Pathway for Cholesterol Homeostasis
  Science, 1986
• Source of cholesterol for the ocular lens, studied with U18666A: A cataract-producing inhibitor of lipid metabolism
  Experimental Eye Research, 1983